May 26, 2022 -- Signant Health debuted Oncology Complete, a full-featured oncology evidence generation product that can be applied to any oncology program from early phase, local studies to multinational trials.
The product includes Signant's SmartSignals electronic clinical outcome assessments (eCOA), eConsent, and randomization and trial supply management (RTSM) software to meet the regulatory expectations for patient-reported outcomes measurement in cancer trials. It allows for at-home or at-site assessments and has the capacity for patient-reported outcomes data capture, informed consent, patient engagement, video visits, and medication management. Oncology Complete can also support investigative sites with its data record capabilities and reconciliation features to promote protocol adherence, for instance, regarding inclusion and exclusion criteria.
Copyright © 2022 scienceboard.net